SRL
APRE icon

Scientech Research LLC’s Aprea Therapeutics APRE Stock Holding History

Scientech Research LLC’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60,281
Closed -$46K – 251
2026
Q1 		$46K Buy
+60,281
New +$47.4K 0.04% 416

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Scientech Research LLC's APRE Position: Q2 2026 in Review

Scientech Research LLC sold out of Aprea Therapeutics (APRE) in Q2 2026, closing a stake of 60,281 shares — an estimated $46K sold.

Scientech Research LLC first reported a position in APRE in Q1 2026 and held it in 1 quarter. The position peaked at $46K in Q1 2026. 28 funds tracked by Wall St. Rank hold APRE as of Q2 2026.

  • Scientech Research LLC reported no remaining Aprea Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 60,281 Aprea Therapeutics shares in Q2 2026, an estimated $46K.
  • Scientech Research LLC first reported a position in Aprea Therapeutics in Q1 2026 and held it in 1 quarter.
  • Scientech Research LLC's Aprea Therapeutics position peaked at $46K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.